Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone injection into the pyelocaliceal space for pain after transureteral lithotripsy
IRCT20210509051237N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Nov 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexamethasone in ureterolithiasis (2 arms), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Primary endpoint: Postoperative analgesics consumption. Started Nov 2023; status: completed.
02
Drugs
dexamethasone
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on IRCT20210509051237N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210509051237N1.